RUBIS: Full-year 2024 results - Another year of strong cash-flow generation
Diversified portfolio at play, with headwinds in Africa offset by strong performance of energy distribution in the Caribbean regionEBITDA of €721m, at the higher-end of the ...
Finanznachrichten4d
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the ...